Metabolic Testing Equipment Market Size, Share, and Trends 2026 to 2035

Metabolic Testing Equipment Market (By Product Type: Metabolic Analyzers, Spirometers, Cardiopulmonary Exercise Testing (CPET) Systems, Body Composition Analyzers, Other Testing Equipment (e.g., Indirect Calorimeters); By Technology: Indirect Calorimetry, Respiratory Gas Exchange Measurement, Bioelectrical Impedance Analysis (BIA), Dual-Energy X-ray Absorptiometry (DEXA), Others; By End-Use: Hospitals, Clinics & Diagnostic Centers, Fitness Centers & Sports Organizations, Research & Academic Institutions, Home Care Settings; By Application: Cardiometabolic Health Monitoring, Obesity & Weight Loss Management, Exercise Physiology & Performance, Nutritional Assessment, Clinical Diagnostics) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2026 to 2035

Last Updated : 23 Apr 2026  |  Report Code : 8337  |  Category : Healthcare   |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Metabolic Testing Equipment Market 

5.1. COVID-19 Landscape: Metabolic Testing Equipment Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Metabolic Testing Equipment Market, By Product Type

8.1. Metabolic Testing Equipment Market Revenue and Volume Forecast, by Product Type

8.1.1. Metabolic Analyzers

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Spirometers 

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Cardiopulmonary Exercise Testing (CPET) Systems 

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Body Composition Analyzers

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Other Testing Equipment (e.g., Indirect Calorimeters)

8.1.5.1. Market Revenue and Volume Forecast

Chapter 9. Global Metabolic Testing Equipment Market, By Technology

9.1. Metabolic Testing Equipment Market Revenue and Volume Forecast, by Technology

9.1.1. Indirect Calorimetry 

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Respiratory Gas Exchange Measurement 

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Bioelectrical Impedance Analysis (BIA) 

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Dual-Energy X-ray Absorptiometry (DEXA)

9.1.4.1. Market Revenue and Volume Forecast

9.1.5. Others

9.1.5.1. Market Revenue and Volume Forecast

Chapter 10. Global Metabolic Testing Equipment Market, By End-Use

10.1. Metabolic Testing Equipment Market Revenue and Volume Forecast, by End-Use

10.1.1. Hospitals

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Clinics & Diagnostic Centers

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Fitness Centers & Sports Organizations

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Research & Academic Institutions 

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Home Care Settings

10.1.5.1. Market Revenue and Volume Forecast

Chapter 11. Global Metabolic Testing Equipment Market, By Application

11.1. Metabolic Testing Equipment Market Revenue and Volume Forecast, by Application

11.1.1. Cardiometabolic Health Monitoring 

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Obesity & Weight Loss Management 

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Exercise Physiology & Performance 

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Nutritional Assessment 

11.1.4.1. Market Revenue and Volume Forecast

11.1.5. Clinical Diagnostics

11.1.5.1. Market Revenue and Volume Forecast

Chapter 12. Global Metabolic Testing Equipment Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Product Type

12.1.2. Market Revenue and Volume Forecast, by Technology

12.1.3. Market Revenue and Volume Forecast, by End-Use

12.1.4. Market Revenue and Volume Forecast, by Application

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Product Type

12.1.5.2. Market Revenue and Volume Forecast, by Technology

12.1.5.3. Market Revenue and Volume Forecast, by End-Use

12.1.5.4. Market Revenue and Volume Forecast, by Application

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Product Type

12.1.6.2. Market Revenue and Volume Forecast, by Technology

12.1.6.3. Market Revenue and Volume Forecast, by End-Use

12.1.6.4. Market Revenue and Volume Forecast, by Application

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Product Type

12.2.2. Market Revenue and Volume Forecast, by Technology

12.2.3. Market Revenue and Volume Forecast, by End-Use

12.2.4. Market Revenue and Volume Forecast, by Application

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Product Type

12.2.5.2. Market Revenue and Volume Forecast, by Technology

12.2.5.3. Market Revenue and Volume Forecast, by End-Use

12.2.5.4. Market Revenue and Volume Forecast, by Application

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Product Type

12.2.6.2. Market Revenue and Volume Forecast, by Technology

12.2.6.3. Market Revenue and Volume Forecast, by End-Use

12.2.6.4. Market Revenue and Volume Forecast, by Application

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Product Type

12.2.7.2. Market Revenue and Volume Forecast, by Technology

12.2.7.3. Market Revenue and Volume Forecast, by End-Use

12.2.7.4. Market Revenue and Volume Forecast, by Application

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Product Type

12.2.8.2. Market Revenue and Volume Forecast, by Technology

12.2.8.3. Market Revenue and Volume Forecast, by End-Use

12.2.8.4. Market Revenue and Volume Forecast, by Application

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Product Type

12.3.2. Market Revenue and Volume Forecast, by Technology

12.3.3. Market Revenue and Volume Forecast, by End-Use

12.3.4. Market Revenue and Volume Forecast, by Application

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Product Type

12.3.5.2. Market Revenue and Volume Forecast, by Technology

12.3.5.3. Market Revenue and Volume Forecast, by End-Use

12.3.5.4. Market Revenue and Volume Forecast, by Application

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Product Type

12.3.6.2. Market Revenue and Volume Forecast, by Technology

12.3.6.3. Market Revenue and Volume Forecast, by End-Use

12.3.6.4. Market Revenue and Volume Forecast, by Application

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Product Type

12.3.7.2. Market Revenue and Volume Forecast, by Technology

12.3.7.3. Market Revenue and Volume Forecast, by End-Use

12.3.7.4. Market Revenue and Volume Forecast, by Application

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Product Type

12.3.8.2. Market Revenue and Volume Forecast, by Technology

12.3.8.3. Market Revenue and Volume Forecast, by End-Use

12.3.8.4. Market Revenue and Volume Forecast, by Application

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Product Type

12.4.2. Market Revenue and Volume Forecast, by Technology

12.4.3. Market Revenue and Volume Forecast, by End-Use

12.4.4. Market Revenue and Volume Forecast, by Application

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Product Type

12.4.5.2. Market Revenue and Volume Forecast, by Technology

12.4.5.3. Market Revenue and Volume Forecast, by End-Use

12.4.5.4. Market Revenue and Volume Forecast, by Application

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Product Type

12.4.6.2. Market Revenue and Volume Forecast, by Technology

12.4.6.3. Market Revenue and Volume Forecast, by End-Use

12.4.6.4. Market Revenue and Volume Forecast, by Application

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Product Type

12.4.7.2. Market Revenue and Volume Forecast, by Technology

12.4.7.3. Market Revenue and Volume Forecast, by End-Use

12.4.7.4. Market Revenue and Volume Forecast, by Application

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Product Type

12.4.8.2. Market Revenue and Volume Forecast, by Technology

12.4.8.3. Market Revenue and Volume Forecast, by End-Use

12.4.8.4. Market Revenue and Volume Forecast, by Application

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Product Type

12.5.2. Market Revenue and Volume Forecast, by Technology

12.5.3. Market Revenue and Volume Forecast, by End-Use

12.5.4. Market Revenue and Volume Forecast, by Application

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Product Type

12.5.5.2. Market Revenue and Volume Forecast, by Technology

12.5.5.3. Market Revenue and Volume Forecast, by End-Use

12.5.5.4. Market Revenue and Volume Forecast, by Application

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Product Type

12.5.6.2. Market Revenue and Volume Forecast, by Technology

12.5.6.3. Market Revenue and Volume Forecast, by End-Use

12.5.6.4. Market Revenue and Volume Forecast, by Application

Chapter 13. Company Profiles

13.1. Cardiometabolic Health Solutions, Inc. 

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Vyaire Medical Inc. 

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Cosmed S.r.l. 

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Schiller AG 

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. GE Healthcare 

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. MGC Diagnostics Corporation 

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Medical Graphics Corporation (MGC Diagnostics) 

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Prometheus Group 

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. KORR Medical Technologies 

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. ParvoMedics 

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The metabolic testing equipment market size is expected to increase from USD 1.90 billion in 2025 to USD 4.38 billion by 2035.

Answer : The metabolic testing equipment market is expected to grow at a compound annual growth rate (CAGR) of around 8.70% from 2026 to 2035.

Answer : The major players in the metabolic testing equipment market include Cardiometabolic Health Solutions, Inc., Vyaire Medical Inc., Cosmed S.r.l., Schiller AG, GE Healthcare, MGC Diagnostics Corporation, Medical Graphics Corporation (MGC Diagnostics), Prometheus Group, KORR Medical Technologies, ParvoMedics, Cerebral Health Technologies, Sable Systems International, BOD POD (COSMED), HITACHI Medical Corporation, and Beurer GmbH

Answer : The driving factors of the metabolic testing equipment market are the increasing global burden of obesity and diabetes is driving demand for metabolic testing equipment by boosting the need for accurate diagnostic and personalized treatment tools.

Answer : North America region will lead the global metabolic testing equipment market during the forecast period 2026 to 2035.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client